Skip to content

Repost: Aimmune Therapeutics, maker of peanut allergy treatment, will be acquired by Nestle

September 1, 2020 by Stephen Tauber

Aimmune Therapeutics, maker of a peanut allergy treatment, said Monday that it will be acquired by the food conglomerate Nestle, which is seeking to expand its health sciences unit. […]

https://www.statnews.com/2020/02/03/new-peanut-allergy-treatment-palforzia-commercial-success-not-assured/